Ambrisentan 10MG 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FATKR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,378
Award facts
- Contract value 100% obligated
- $10,377.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) on January 6, 2026, for the supply of Ambrisentan 10mg tablets in a 30-count configuration, with a ceiling value of $10,377.51. This is a firm fixed-price delivery order with no set-aside designation, indicating the award resulted from open and full competition. The place of performance is Conshohocken, Pennsylvania, with an ultimate completion date of February 3, 2026. This delivery order is issued under Amerisourcebergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare systems worldwide.
Ambrisentan is an endothelin receptor antagonist used in the treatment of pulmonary arterial hypertension, reflecting the critical pharmaceutical support that Amerisourcebergen provides to military healthcare programs. The company's federal contract portfolio demonstrates its established capability to deliver specialized pharmaceutical commodities efficiently across multiple therapeutic domains. The non-set-aside status and firm fixed-price structure are consistent with Amerisourcebergen's competitive positioning within the federal pharmaceutical supply chain and its role as a primary vendor supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FATKR?
SPE2DR26FATKR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FATKR worth?
The government has obligated $10,378 on SPE2DR26FATKR.
Is contract SPE2DR26FATKR an order under another contract?
Yes. SPE2DR26FATKR is a delivery order under SPE2DR25D6028, an indefinite delivery contract.
Was contract SPE2DR26FATKR competed?
The extent of competition for SPE2DR26FATKR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award